News

UnitedHealth, Prescription Solutions and the National Council on Patient Information and Education (NCPIE) have released a new survey, which shows that 54% of Americans say they do not

Sanofi-aventis is due to announce the results of cross-sectional study of ‘SITE’ (Screening India’s Twin Epidemic). The objective of the study was to quantify and instill awareness amongst

“HairDX is a very valuable tool to determine early stages of Androgenetic Alopecia. Noninvasive treatment possibilities are greatly enhanced by early action on Androgenetic Alopecia,” says Dr. Carlos

Pfizer has announced that as apart of global research facility strategy under Wyeth merger, will close six sites including New London facility. The staff froms New London facility

Nutra Pharma has reported that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing

Tokyo CRO and Ecron Acunova have formed a strategic alliance strengthening their services in India, Europe and Japan providing sponsors with a global network. The alliance will provide

Shire has reported findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity

Lexicon Pharmaceuticals has reported that the company’s investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating

The researchers of Riken and Yokohama City University have reported that a key mechanism involved in immune surveillance in the intestinal system. Their research is expected to appear